Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 548i-4 is a small non-coding RNA molecule belonging to the microRNA (miRNA) family, typically 20–24 nucleotides in length, that regulates gene expression in multicellular organisms by influencing the stability and translation efficiency of target mRNAs[1]. It is produced as part of a primary transcript by RNA polymerase II, proceeds through specific cleavage steps to yield the mature miRNA, and is loaded into the RNA-induced silencing complex (RISC) to modulate gene expression post-transcriptionally[1]. Members of the miRNA-548 family, including MIR548I4, have been implicated as potential biomarkers for early heart failure due to their unique downregulation in peripheral blood mononuclear cells from patients with dilated cardiomyopathy, though no direct therapeutic targeting or drug interactions are currently documented[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 548i-4 (MIR548I4).